Somatic outcomes in a phase 1/2 study of weekly intravenous DNL310 (brain-penetrant enzyme replacement therapy) in mucopolysaccharidosis type II
Barbara Burton,Joseph Muenzer, Paul Harmatz,Deepa Rajan,Simon A. Jones, Hannerieke J. P. van den Hout,John Mitchell, Katia Meirelles, Natalie Engmann, Adam Scheller, Rupa Caprihan,Akhil Bhalla, Tony Hung, Jason Nachtigall, Imanol Zubizarreta, Sam Lu,Yuda Zhu,Peter Chin, Matt D. Troyer,Carole Ho, Wei Dong,Fabian Model,Anna I. Bakardjiev MOLECULAR GENETICS AND METABOLISM（2024）
AI 理解论文
溯源树
样例
